AXE COMPUTE INC
AGPUNASDAQTrading Snapshot
- Day Range
- $8.65 β $9.04
- 52-Week Range
- $1.03 β $13.49
- Volume (shares)
- 6,921
- Avg Volume (shares)
- β
- Shares Outstanding
- 11.6M
- Next Earnings
- 2026-11-12
Fundamentals Snapshot
- Annual Revenue
- $125,284
- Last Q Revenue
- $3M
- P/E Ratio
- β
- P/S Ratio
- 31.0x
- EPS (TTM)
- $-117.15
- Dividend Yield
- β
- Dilution (1yr)
- +288.5%
AXE COMPUTE INC
AGPUAbout AXE COMPUTE INC
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
News unavailable.